首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5771篇
  免费   559篇
  国内免费   856篇
  2024年   14篇
  2023年   76篇
  2022年   224篇
  2021年   309篇
  2020年   226篇
  2019年   253篇
  2018年   218篇
  2017年   194篇
  2016年   230篇
  2015年   362篇
  2014年   426篇
  2013年   484篇
  2012年   585篇
  2011年   491篇
  2010年   342篇
  2009年   341篇
  2008年   371篇
  2007年   329篇
  2006年   258篇
  2005年   279篇
  2004年   226篇
  2003年   209篇
  2002年   170篇
  2001年   106篇
  2000年   82篇
  1999年   78篇
  1998年   93篇
  1997年   47篇
  1996年   29篇
  1995年   26篇
  1994年   23篇
  1993年   13篇
  1992年   18篇
  1991年   14篇
  1990年   7篇
  1989年   3篇
  1988年   5篇
  1987年   2篇
  1986年   4篇
  1985年   8篇
  1984年   4篇
  1983年   2篇
  1982年   2篇
  1981年   1篇
  1973年   1篇
  1967年   1篇
排序方式: 共有7186条查询结果,搜索用时 890 毫秒
941.
黄花牛耳朵(苦苣苔科)的传粉生物学   总被引:1,自引:0,他引:1  
通过野外观察和繁育系统的实验,对黄花牛耳朵(Chirita lutea Yan Liu et Y.G.wei)的传粉生物学进行了研究.结果表明,黄花牛耳朵的花期从7月初至8月底,单株花期约35~47 d,单花化期约6~10 d,花的开放无固定的时间.在花期内花粉活性约80%,柱头可授性约75%~90%.花粉/胚珠比率(P/O)为1 215.73±266.13.柱头在花药散粉时已生长至花筒口部,明显高于花药,便于接受异花花粉.黄花牛耳朵不存在无融合生殖,高度白交亲和,但较难发生自动的白花授粉,产生种子主要依靠传粉媒介.自然授粉的结实率明显低于人工授粉的结实率,存在传粉限制,蜜蜂(Apidae sp.)、方头泥蜂(Crabro sp.)、无垫蜂(Ameglla sp.)是主要的传粉者.  相似文献   
942.
免疫缺陷动物是研究免疫相关疾病的良好动物模型。Beige-Nude小鼠是T淋巴细胞和NK细胞同时缺陷的小鼠,其T细胞和NK细胞活性很低,最初为肿瘤的研究而培育。从上世纪七十年代起,学者们对其免疫学特性进行了广泛而深入的研究,为其在其他领域的应用奠定了免疫学基础。  相似文献   
943.
944.
探讨过表达特异AT序列结合蛋白-1 ( special AT-rich sequence binding protein ,SATB1)核基质结合区(MAR)结合蛋白对胰岛素样生长因子结合蛋白-2(IGFBP2)基因表 达的影响,并对其影响机制进行初步探索.首先用脂质体将SATB1的真核表达载体pcDNA3.1-SATB1转染至K562细胞,通过6周G418的筛选获得阳性克隆,RT-PCR、实时PCR及Western 印迹验证过表达情况,对阳性克隆细胞中IGFBP2的表达用RT-PCR、实时PCR及Western 印迹方法进行检测;然后用RNAi的方法干扰阳性细胞中SATB1 的表达后,同样用上述3种方法再次检测IGFBP2的表达状况;用生物信息学方法对IGFBP2基因进行MAR序列与SATB1结合位点搜索分析,寻找SATB1影响IGFBP2基因表达的机制.结果显示,在稳定转染的情况下,实验组K562-SATB1细胞与转染空载体pcDNA3.1的K562-3.1细胞和未转染细胞K562相比,IGFBP2 mRNA水平上调了近7倍,而蛋白水平变化不明显.RNA干扰后,IGFBP2的表达在mRNA水平也相应下调,蛋白水平的变化同样不明显.通过生物信息学分析发现,IGFBP2第1个内含子中可能存在2. 5 kb MAR样序列,且MAR样序列上存在多个SATB1的潜在结合位点.综上所述,过表达SATB1可以使K562细胞中IGFBP2 mRNA表达水平提高,而且其调控机制可能与SATB1直接和IGFBP2基因中的MAR样序列结合有关.  相似文献   
945.
为分析乳腺癌易感基因2(breast cancer susceptibility gene 2, BRCA2)蛋白与中心体BRCA2相互作用蛋白(centromal BRCA2 interacting protein, centrobin)间相互作用及其细胞定位的关系,探讨二者功能上的联系,本研究采用哺乳细胞双杂交实验检测体内结合并初步判定BRCA2分子上的结合区域;免疫共沉淀实验进一步验证其体内结合活性,GST-pulldown法检测其体外结合活性,免疫组织化学染色观测BRCA2蛋白的细胞定位及在有丝分裂各期centrobin的细胞定位.结果显示,BRCA2与centrobin间存在体内和体外结合,且BRCA2分子的结合区域主要位于2 393~2 952氨基酸残基处;外源表达BRCA2定位于中心体,在有丝分裂各时相centrobin均定位于中心体. BRCA2与centrobin在体内形成复合物,并存在直接物理结合作用,二者存在细胞空间定位的一致性.该结果为进一步研究BRCA2在中心体复制中的调控作用提供了线索.  相似文献   
946.
Bone marrow stromal cell antigen 2 (BST-2, also known as tetherin) restricts the production of a number of enveloped viruses by blocking virus release from the cell surface. This antiviral activity is counteracted by such viral factors as Vpu of human immunodeficiency virus type 1 (HIV-1). Here, we report that Vpu antagonizes human BST-2 but not BST-2 derived from African green monkeys. The determinants of susceptibility to Vpu map to the transmembrane domain of BST-2. In accordance with this, expression of human BST-2 containing a modified transmembrane domain effectively blocks the replication of wild-type Vpu-expressing HIV-1 in CD4+ T cells. Furthermore, these BST-2 variants, as opposed to wild-type human BST-2, are refractory to Vpu-mediated down-regulation as a result of an attenuated interaction with Vpu. In view of the work by others pointing to a key role of the transmembrane domain of Vpu in promoting virus release, our data suggest that a direct interaction through the transmembrane domain of each of these two proteins is a prerequisite for Vpu to down-modulate BST-2.Human immunodeficiency virus type 1 (HIV-1) encodes four accessory proteins, Vif, Vpr, Vpu, and Nef. Although they are dispensable for HIV-1 replication in certain transformed cell lines, these accessory proteins play important roles in HIV-1 pathogenesis by modulating host immunity and overcoming antagonism by cellular factors (10). For example, Vif counteracts APOBEC3G by recruiting the cullin 5-elongin B/C ubiquitin ligase complex and sending polyubiquitinated APOBEC3G to proteasomes for degradation (29). In the absence of Vif, newly synthesized APOBEC3G is incorporated into virus particles and hampers the production of infectious proviral DNA in the new round of infection (4, 10, 23). In addition to its role in down-modulating the cell surface expression of CD4 in infected T cells (11), Vpu stimulates HIV-1 production in cells such as HeLa cells (26). The mechanism behind this latter activity of Vpu was unknown until it was recently discovered that bone marrow stromal cell antigen 2 (BST-2, also known as tetherin, CD317, or HM1.24) blocks the release of HIV-1 and that this inhibitory effect is antagonized by viral Vpu (16, 25).BST-2 harbors an N-terminal transmembrane domain and a C-terminal glycosyl-phosphatidylinositol anchor that together create an unusual topology with both termini of BST-2 inserted into the plasma membrane (8, 18). This unique topology of BST-2 may underlie the mechanism for the retention of progeny virus particles at the cell surface (16). An indirect mechanism behind this tethering effect has not been ruled out, especially in view of the difficulty of detecting BST-2 protein in purified HIV-1 particles (14). In addition to HIV-1, a number of enveloped viruses are subject to inhibition by BST-2, including simian immunodeficiency virus, feline immunodeficiency virus, equine infectious anemia virus, Mason-Pfizer monkey virus, and Lassa virus, as well as Ebola and Marburg viruses (5, 6, 16, 19, 25). This suggests that BST-2 has a broad antiviral effect spectrum.The bst-2 gene has in its promoter the IRF-1/2 and ISGF3 response elements and thus belongs to the interferon-stimulated gene family (17). In line with its ability to impair the release of enveloped viruses, BST-2 has been demonstrated to be the effector in human embryonic kidney (HEK293T) cells that leads to the interferon-induced block of Vpu deletion-containing HIV-1 production (15). However, the African green monkey kidney cell line COS-7 responds to interferon treatment with a different outcome in that the production of both Vpu deletion-containing and Vpu-expressing HIV-1 is inhibited (15). This indicates that interferon induces a block to HIV-1 in COS-7 cells that cannot be overcome by Vpu. A conceivable candidate that creates this block is BST-2 in COS-7 cells (hereafter named agmBST-2). In this study, we provide evidence that depletion of endogenous BST-2 in COS-7 cells greatly alleviates interferon-induced inhibition of HIV-1 production. The refractoriness of agmBST-2 to Vpu results from a weak association of these two proteins and a resistance of agmBST-2 to Vpu-mediated down-regulation.  相似文献   
947.
广西种子植物新资料   总被引:2,自引:1,他引:1  
林春蕊  邹蓉  刘演 《广西植物》2009,29(3):309-310
报道了广西种子植物分布新记录3种:剪红纱花、头花水玉簪、大柱莓草,其中霉草科和喜荫草属分别为广西新记录科和新记录属;以及原来被认为在广西已经灭绝的广西重点保护植物胡豆莲也被重新发现。  相似文献   
948.
A new series of flavonoid derivatives have been designed, synthesized and evaluated as potent AChE inhibitors. Most of them showed more potent inhibitory activities to AChE than rivastigmine. The most potent inhibitor isoflavone derivative 10d inhibit AChE with a IC50 of 4 nM and showed high BChE/AChE inhibition ratio (4575-fold), superior to donepezil (IC50 = 12 nM, 389-fold). Molecular docking studies were also performed to explore the detailed interaction with AChE.  相似文献   
949.
目的研究2型糖尿病大鼠心肌胰岛素信号转导通路蛋白胰岛素受体(IR)、胰岛素受体底物-1(IRS-1)的表达与正常SD大鼠的区别,并探讨进行罗格列酮及APP5肽类似物P165干预后对上述蛋白表达的影响。方法60只SD大鼠随机分为正常对照组(C组)、正常对照+罗格列酮组(C+RSG组)、2型糖尿病组(T2DM组)、2型糖尿病+罗格列酮组(T2DM+RSG组)、糖尿病给予P165小剂量组(T2DM+P165小剂量组)、糖尿病给予P165大剂量组(T2DM+P165大剂量组),其中糖尿病动物采用高脂饮食后给予小剂量STZ腹腔注射的方法造模。后将各组SD大鼠处死,采用免疫组织化学染色和Western blot的方法检测心肌组织IR、IRS-1的表达。结果(1)2型糖尿病组(T2DM组)心肌组织IR、IRS-1的表达水平显著低于对照组(C组);(2)2型糖尿病+罗格列酮组(T2DM+RSG组)心肌组织IR、IRS-1的表达水平显著高于T2DM组;(3)免疫组化染色发现2型糖尿病+P165小/大剂量组(T2DM+P165小/大剂量组)心肌组织IR、IRS-1免疫反应阳性颗粒沉着的累积光密度值显著高于T2DM组;Western blot结果显示T2DM+P165小/大剂量组心肌组织IRS-1的表达水平显著高于T2DM组;而IR的表达水平与T2DM组相比无差别。结论(1)2型糖尿病大鼠心肌存在胰岛素抵抗或信号转导障碍;(2)罗格列酮干预后可以改善2型糖尿病心肌的胰岛素信号转导异常;(3)P165对2型糖尿病大鼠心肌胰岛素信号转导具有调节作用,其作用靶点可能为胰岛素受体底物。  相似文献   
950.
Natural resistance associated macrophage protein 1 (Nramp1), an integral membrane protein with 12 predicted transmembrane domains (TMs), is a divalent cation transporter associated with infectious and autoimmune diseases. A naturally occurring mutation G169D within TM4 of Nramp1 leads to the loss of function, suggesting potential importance of TM4 for the biological function of the protein. In this study, we determine the three‐dimensional structure and topology of a synthetic peptide, del(T178), corresponding to Nramp1(164‐191) (basically consisting of the putative TM4 of Nramp1) with Thr178 deletion in TFE and SDS micelles using NMR and CD spectroscopic techniques, and compare the results with those of the wildtype peptide. Similarly to the wildtype peptide, the del(T178) peptide still forms an amphiphilic‐like α‐helical structure in both membrane mimics and is embedded in SDS micelles. Differently, whereas the wild‐type peptide forms a helix bundle with the hydrophilic side facing the interior of the bundle, the del(T178) peptide exists as a monomer in the membrane mimics and the hydrophilic side of the helix is located near the interface of SDS micelles. Moreover, a strongly cooperative protonation occurs between intramolecular Asp residues for the del(T178) peptide in SDS micelles, while the cooperative proton binding between intermolecular Asp residues was observed for the wildtype peptide. The difference in the results of the two peptides suggests that the deletion of Thr178 impairs intermolecular interaction of the peptide. Copyright © 2009 European Peptide Society and John Wiley & Sons, Ltd.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号